Showing results (101-110 of 187) with videos related to
Sort By:
Pageof 19
International Journal of Pharmaceutics|March 4, 2000
Nanosuspensions of poorly soluble drugs--reproducibility of small scale productionM J Grau, O Kayser, R H MüllerInternational Journal of Pharmaceutics|July 30, 1999
An investigation into the distribution of lecithins in nanosuspension systems using low frequency dielectric spectroscopyK Peters, R H Müller, D Q CraigClinical Nutrition (Edinburgh, Scotland)|October 1, 1992
Particle size, surface hydrophobicity and interaction with serum of parenteral fat emulsions and model drug carriers as parameters related to RES uptakeH Carrstensen, R H Müller, B W MüllerEuropean Journal of Biochemistry|November 2, 1987
Completion of the amino acid sequence of the alpha 1 chain of human basement membrane collagen (type IV) reveals 21 non-triplet interruptions located within the collagenous domainD Brazel, I Oberbäumer, H Dieringer, et al.Journal of Food Science|February 27, 2008
Beta-carotene-loaded nanostructured lipid carriersA Hentschel, S Gramdorf, R H Müller, et al.Die Pharmazie|March 16, 2010
Preserving hesperetin nanosuspensions for dermal applicationL Al Shaal, R H Müller, C M KeckInternational Journal of Pharmaceutics|March 4, 2000
Interactions of nanoparticles with body proteins--improvement of 2D-PAGE-analysis by internal standardK Seehof, M Kresse, K Mäder, et al.Die Pharmazie|October 15, 2005
Rheology of nanostructured lipid carriers (NLC) suspended in a viscoelastic mediumE B Souto, S H Gohla, R H MüllerInternational Journal of Pharmaceutics|January 5, 2002
Effect of lipid matrix and size of solid lipid nanoparticles (SLN) on the viability and cytokine production of macrophagesN Schöler, H Hahn, R H Müller, et al.Die Pharmazie|June 25, 2011
Nanostructured lipid carriers as delivery system for the phopholipase A2 inhibitors PX-18 and PX-13 for dermal applicationJ Pardeike, C Schmidt, I Volz, et al.Pageof 19